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Emerging infectious diseases (EIDs) threaten the health of people, animals, and 
crops globally, but our ability to predict their occurrence is limited. Current 
public health capacity and ability to detect and respond to EIDs is typically 
weakest in low- and middle-income countries (LMICs). Many known drivers of 
EID emergence also converge in LMICs. Strengthening capacity for surveillance 
of diseases of relevance to local populations can provide a mechanism for 
building the cross-cutting and flexible capacities needed to tackle both the 
burden of existing diseases and EID threats. A focus on locally relevant diseases 
in LMICs and the economic, social, and cultural contexts of surveillance can help 
address existing inequalities in health systems, improve the capacity to detect 
and contain EIDs, and contribute to broader global goals for development.  
  
 For an increasingly interconnected planet, emerging infectious diseases (EIDs) 
pose profound threats to human health, the animals and crops we depend upon, 
and ultimately the economies and societies that sustain us. Although there is 
widespread recognition of the need for effective surveillance, there is less clarity 
about how to achieve this. Approaches that promise the ability to predict and 
thus prevent disease outbreaks have obvious attraction (1). However, despite 
important insights into the dynamics of cross-species transmission (2, 3), risk 
factors associated with EID events (4–6), and determinants of spread and 
persistence (3, 7), we still have limited ability to identify when and where new 
disease events will occur. 
 
The current state of global capacity for EID surveillance shows geographic 
variation in outbreak distribution, detection, and reporting times. More than half 
(53%) of all outbreaks reported to the World Health Organization (WHO) from 
1996 to 2009 were from Africa, the region with the longest delays in detection 
and public communication (8). Globally, delays are inversely related to the 
Human Development Index (9). Despite the implementation of the International 
Health Regulations (IHR) (10), which mandate countries to develop surveillance 
systems and response capacities to contain epidemics, fewer than 20% of United 
Nations member states have achieved the required standards (11). 
 
The absence and/or breakdown of public health measures has been identified as 
by far the most important factor underlying the occurrence of infectious disease 
outbreaks of international concern (12). Although the precise location of the next 
EID event cannot be predicted, regions where public health capacity is currently 
weak are readily identifiable: typically in low- and middle-income countries 
(LMICs), where many of the known drivers of EID emergence [deforestation, 
rapid urbanization, and agricultural intensification (13)] also converge. For 
wildlife-associated EIDs, emergence events occur most often where dense 
human populations intersect with areas of high species richness (5), again, 
mostly in LMICs. There is thus a clear rationale for strengthening disease 
surveillance in LMICs. 
 Surveillance systems and responsive interventions are often designed for a 
specific disease; however, many components of surveillance and response 
systems are not disease-specific. Numerous surveillance systems and 
organizations, established originally with a focus on a specific locally relevant 
disease, have subsequently leveraged their capacities to tackle other threats, 
including EIDs. For example, laboratories established through the Global Polio 
Eradication Initiative have expanded to cover pathogens including hemorrhagic 
fevers, Japanese encephalitis, severe acute respiratory syndrome, H5N1 
influenza, and, most recently, Ebola virus disease (14, 15). The International 
Centre for Diarrhoeal Disease Research Bangladesh, established as a cholera 
research laboratory, now conducts research into diverse public health threats 
across a wider region. The predecessor organization of the U.S. Centers for 
Disease Control and Prevention (CDC) was established to control malaria, and 
cholera control was the initial impetus for the creation of today’s Pan American 
Health Organization and WHO. In the veterinary sector, the infrastructures 
established through the Pan African Rinderpest Campaign are now central to the 
Food and Agriculture Organization’s Emergency Prevention System for 
Transboundary Animal and Plant Pests and Disease (EMPRES). The participatory 
epidemiology approaches and improved animal health delivery systems for 
marginalized communities developed for Rinderpest have since been applied to 
control peste des petit ruminants, Rift Valley fever, highly pathogenic avian 
influenza, and foot-and-mouth disease (16). Specific advantages of eradication 
programs, in terms of legacy effects, emerge from their broad geographic scope 
and networks of trained health workers. The need to demonstrate freedom from 
disease requires verifiable and rigorous targets to be met even in the most hard-
to-reach communities (16). 
 
EID surveillance requires a network of trained reporters who can recognize and 
communicate disease events and systems to receive, collate, and disseminate 
reports. As the majority of EIDs are zoonoses, integration of surveillance 
capacities across human and animal health sectors is needed (1, 5, 11). Crucially, 
disease surveillance and the implementation and evaluation of interventions to 
contain the disease threat must be linked. Surveillance data inform control 
measures, and useful responses incentivize future data collection and reporting 
(Fig. 1) (1). Investments in sustainable surveillance programs must ultimately be 
linked to tangible health improvement outcomes (17). 
 
Fig. 1. Surveillance cycles for current and potential disease problems.  
The lower  cycle illustrates the self-reinforcing nature of effective surveillance 
processes for existing disease problems. The upper cycle illustrates the 
equivalent processes for potential disease problems. Because it is difficult to 
implement interventions for potential disease threats that provide a useful 
response, and thus motivate further grassroots data collection, this cycle is less 
intrinsically sustainable, limiting the long-term effectiveness of approaches that 
focus on EIDs and potential threats alone. The vertical arrows show how 
capacity for potential disease problems and EID surveillance overall can be built 
by “borrowing” critical capacities (shown by the vertical arrows) from 
approaches that focus on existing diseases. 
 
Prioritizing action to tackle existing diseases  
A focus on strengthening capacity for surveillance of existing diseases that are of 
relevance to local populations can provide a mechanism for building the 
adaptable surveillance capacities that are also needed to tackle EID threats. Our 
rationale is that the act of focusing on locally relevant and ongoing disease 
threats enables greater local engagement and improves the chances of successful 
disease control by recognizing the social determinants of health (17–19). “Soft” 
organizational capacities, including communication, trust building, diplomacy, 
networking, political advocacy, and leadership are critical for health systems 
improvement (19). Aligning capacity-strengthening for EIDs with locally relevant 
disease control efforts can overcome many of the challenges inherent in building 
de novo systems for EIDs. Additional benefits to such a pragmatic approach 
include synergies with multiple sustainable development goals (SDGs) (12, 17). 
 
There are several existing frameworks that can be used to evaluate surveillance 
capacities and  identify capacity-strengthening needs for both EIDs and existing 
disease challenges. These include the Performance of Veterinary Services path-
 way of the World Organisation for Animal Health,  IHR targets (10), tools 
defining core competencies  for surveillance at the human-animal 
interface  (20), and tools for zoonotic disease prioritization developed through 
the Global Health Security Agenda (21). One Health approaches are important 
for zoonotic disease risks, but equally, tackling nonzoonotic human diseases or 
economically important livestock diseases may be the most effective way to 
build the capacity needed in many cases. No single approach to the selection of 
locally relevant diseases (be they infectious, noncommunicable, endemic, or 
emerging) will be appropriate in all settings. A case study illustrating how 
actions to control rabies—a locally relevant zoonosis in many LMICs—contribute 
to strengthening of surveillance capacities for EIDs and global goals for 
sustainable development is given in table S1.  
 
Understanding surveillance in context  
Surveillance is costly; hence, any perceived lack of benefits is particularly 
discouraging for stakeholders, including patients, livestock keepers, healthcare 
providers, and governments. Aligning private incentives with local and global 
public benefits is key, and a focus on locally relevant disease problems can help 
achieve this. Surveillance costs to livestock keepers, for example, may include 
time contacting a private- or public-sector animal health official and paying for 
their services, actions that require a clear private benefit to that farmer. In the 
absence of effective veterinary responses, surveillance relying on individual 
livestock keepers will collapse. This is all too often the case for animal (and 
human) health surveillance initiatives in many LMIC settings, with the 
unsurprising result that endemic diseases are chronically underreported. Where 
surveillance is focused on potential disease threats, and the nature of the 
appropriate response to a novel threat is unknown, the potential benefits of 
participation are impossible to measure, thus compounding this problem.  
 
The potential benefits of disease reporting actions by a livestock keeper range 
from private benefits, when early detection and reporting minimize income loss 
from sick animals, to the spillover benefits to other local households from 
reduced disease incidence. Further, there will be national benefits, such as 
human health risk reductions of zoonoses, economic benefits of a healthier 
livestock sector, and reduced transmission from and to wildlife (22). Finally, 
there will be advantages from the increased capacity to detect EIDs rapidly and 
minimize their spread and impact worldwide. The wider-ranging benefits are 
less tangible to individual livestock keepers and of little incentive. Despite these 
far-reaching benefits, the major surveillance costs fall on local stakeholders, who 
will only partially gain benefits. For national or global programs to be able to rely 
on grassroots disease monitoring, it is important to ensure that individuals 
benefit by subsidizing or rewarding participation in surveillance activities—for 
example, via incentive payments or through involvement with institutions 
created for coordination and benefit-sharing across communities. These could 
include, for example, cooperatives of livestock farmers acting together on 
surveillance and disease control behavior to generate greater benefits in total 
than if each person acted according to individual interests and provides a 
mechanism for sharing these benefits. It is important to identify who should fund 
such programs and how best to design cooperative institutions (23). 
 
If the long-term outcome is improved global capacity to detect and respond to 
EIDs, the entire global population benefits. A key question, therefore, is whether 
richer beneficiaries should pay for surveillance by the individuals who supply 
this public good. If so, investments in tackling diseases in LMICs that will 
improve global EID surveillance capacity should be funded by Western 
governments, development banks, or aid agencies. The design of systems to 
tackle misalignments of costs and benefits must also consider the best form in 
which incentives can be provided (1). Theoretical models that identify when it is 
best to subsidize actions rather than outcomes, or a combination of the two, 
provide compelling solutions to analogous questions in biodiversity 
conservation (24). 
 
New technologies, including mobile phones, have potential to facilitate real-time 
communication and improve surveillance capacity if adopted for routine use. For 
example, a recent large-scale mobile-phone–based system in southern Tanzania 
improved rabies surveillance data quality and timeliness at low cost in 
comparison to paper-based surveillance (25). Regular phone communications 
and feedback supported users, particularly in isolated areas, and incentivized 
surveillance. Importantly, this system was designed by government 
representatives, community members, and system users. Integrating these 
technologies within widely used surveillance platforms such as DHIS2 could 
facilitate their uptake and simplify demands on health and veterinary workers 
(26). 
 
Public health interventions often fail because of a lack of attention to their social, 
cultural, and historical contexts and engagement with the people they are 
designed to benefit. Effective community engagement has been crucial for 
successful control of Ebola in West Africa (27), rinderpest eradication (16), and 
the success of many neglected tropical disease (NTD) programs (28). Indeed, the 
need to tailor delivery strategies to local contexts is a common finding from 
social science studies of NTD programs (18), and there is no reason to think that 
this any less necessary for other infectious disease challenges, including 
surveillance (17, 19). 
 
Research is vital to understand the relative importance of disease alongside 
other priorities for individual households, perceptions of ability to effect change, 
and the situations required for action to be taken. Even in the midst of epidemics, 
attitudes toward disease risk and management, for instance, may not be focused 
around one pathogen, or even on avoiding disease at all, but on providing food, 
income, education, or investment for the future. Local understanding of disease, 
relationships to government officials and the state, and past experiences with 
development projects play important mediating roles in community engagement 
with disease control and capacity-strengthening programs (18, 29). The causes 
of social difference are complex: It is not always possible to address these 
through individual behavior change and, instead, wider social, economic, and 
political processes must be understood. One Health approaches offer an 
advantage here because they can offer a broader understanding of the 
interdependencies of human, animal, environmental, and socioeconomic health 
in the decision-making of households, in addition to the likely effects of disease 
control interventions. However, interventions are unlikely to be adopted if 
individuals perceive that they lack the agency to enact change. Focusing on 
tangible and tractable current problems can help to empower individuals.  
 
Maximizing synergies and sustainability  
By focusing on detecting and reporting rare EID events independently of other 
disease problems, we miss important opportunities for broader-reaching 
benefits and synergies. Appropriately targeted improvements in surveillance 
capacity can be viewed as investments in a country’s “inclusive wealth,” argued 
to be a key factor in determining a country’s ability to achieve sustained 
improvements in well-being (30). Our proposed strategy reflects a growing 
global interest in optimizing interactions across the SDGs (31). Progress toward 
the SDG3.d target relating to EIDs—to strengthen capacity of all countries, in 
particular developing countries, for early warning, risk reduction, and 
management of national and global health risks—depends on several other SDG3 
targets, including access to good-quality essential health-care services. Efforts to 
manage a locally relevant disease can also contribute to ending neglected 
tropical diseases (SDG3.3) and achieving universal health coverage (SDG3.8). 
Interventions that support targets for sustainable cities and communities 
(SDG11) could be designed with a view to detecting and mitigating emerging 
vector-borne threats, such as Zika, chikungunya, and yellow fever viruses, which 
are all transmitted by urban-adapted species of Aedes mosquito vectors. 
Interventions to support sustainable and resilient agricultural practices that help 
maintain diverse ecosystems (SDG2) could be developed to mitigate against the 
land-use changes that have been linked with spillover transmission and disease 
emergence from wildlife reservoirs. 
 
The components and requirements of effective global EID surveillance are 
known, but there has been less focus on the mechanisms that can be employed to 
strengthen the capacities needed. This is particularly true in LMICs with the 
weakest human and animal health systems, where many diseases have emerged 
and where the consequences of EID events are likely to be most serious. Many of 
the capacities required for EID surveillance are identical to those required to 
tackle existing diseases of ongoing local importance. We argue for an approach 
whereby gaps in EID surveillance capacity are filled by responding to existing 
local health challenges rather than through a focus on EIDs exclusively. The 
investments required to achieve comparable capacity gains through an EID-only 
strategy are likely to be greater and ultimately unsustainable. In contrast, 
approaches to EID capacity building that address locally relevant disease 
problems can capitalize on positive reinforcement processes that will sustain the 
capacities and collaborative networks that make up a functional surveillance 
system. By addressing ongoing disease problems, greater understanding of the 
social determinants and context of disease response capability in low-resource 
settings can be built, generating insights that apply far beyond the initial target 
disease. This approach provides a mechanism for achieving the necessary 
improvements in global EID surveillance capacity while also contributing to 
broader global goals for development. 
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 SUPPLEMENTARY MATERIALS  
Table S1. 
Case study to show how actions to achieve control and elimination of rabies, 
contribute to capacity-strengthening for EID surveillance and achievement of 
sustainable development goals. 
The capacities listed in the second and third columns align to the IHR-PVS (20) 
and GHSA (21) frameworks respectively. *IHR-PVS capacity on zoonoses (10.1) 
and GHSA Action Package on Zoonotic Diseases (Prevent 2) apply throughout. 
 
Action on a 
locally relevant 
disease: Control 
and elimination 
of rabies 
Relevant 
capacities and 
competencies 
within IHR-PVS 
Monitoring 
Framework* 
Relevance to 
Global Health 
Security Action 
Packages* 
Interactions with 
Sustainable 
Development Goals 
and Targets 
Ensure 
notifiability of 
human and 
animal rabies 
National 
legislation and 
policy, 
epidemiological 
surveillance 
Detect 2,3: Real-
time surveillance 
SDG 3.d Early 
warning, risk 
reduction and 
management of 
national and global 
health risks 
Training of 
human and 
animal health 
workers in 
integrated bite 
case management 
and outbreak 
investigation 
(required for all 
suspect 
exposures when 
aiming to verify 
freedom from 
rabies/ 
interruption of 
transmission) 
Human resource 
capacity, 
including 
veterinary, para-
professionals 
and other 
professionals; 
diagnostic and 
laboratory 
capacity; 
intersectoral 
coordination; 
emergency 
response; risk 
communication 
Detect 1: 
National 
laboratory 
system; Detect 
2,3: Real-time 
surveillance 
system, multi-
sectoral 
surveillance 
data; Detect 5: 
Workforce 
development 
SDG 3.c: Training, 
retention of health 
workforce; SDG 3.d 
Early warning, risk 
reduction and 
management of 
national and global 
health risks 
Interventions: 
Emergency access 
to life-saving 
human vaccines; 
large-scale mass 
dog vaccination; 
washing of animal 
bite injuries to 
reduce rabies 
Management of 
resources and 
operations; 
consultation and 
stakeholder 
participation; 
disease 
prevention, 
control and 
Prevent-4: 
Immunization 
action package; 
Respond 1: 
Emergency 
operations 
(multi-sectoral 
response teams) 
SDG 3.b: Access to 
affordable vaccines; 
SDG 3.8: Achieve 
universal health 
coverage, including 
access to safe, 
effective, quality and 
affordable vaccines 
for all; SDG 3.3: End 
risk; dog 
population 
management 
eradication; 
management of 
resources and 
operations 
epidemics of 
neglected tropical 
diseases (rabies); 
SDG 6.2: Achieve 
access to adequate 
and equitable 
sanitation; SDG 11.6: 
Urban waste 
management; SDG 
15.5: Protect and 
prevent extinction of 
threatened species 
Vaccine 
procurement, 
distribution and 
delivery 
Coordination 
capability; 
management of 
resources and 
operations; 
operational 
funding; 
forecasting 
capacity 
Prevent-4: 
Immunization 
action package 
SDG 3.b: Provide 
access to affordable 
vaccines; 3.8: Achieve 
universal health 
coverage, including 
access to safe, 
effective, quality and 
affordable vaccines 
for all 
Establishment of 
One 
Health/Zoonoses 
coordination 
units 
Intersectoral 
coordination; 
disease 
prevention, 
control and 
eradication; 
emergency 
response; 
management of 
resources and 
operations 
Respond 1: 
Emergency 
operations 
(multi-sectoral 
response teams) 
SDG 3.c: Training, 
retention of health 
workforce; SDG 3.d 
Early warning, risk 
reduction and 
management of 
national and global 
health risks 
Detection and 
diagnosis of 
human cases of 
acute encephalitis 
syndrome 
(required to 
validate freedom 
from human 
rabies) 
Epidemiological 
(syndromic) 
surveillance; 
diagnostic 
capacity 
Detect 2,3: Real-
time surveillance 
(syndromic 
surveillance) 
SDG 3.d Early 
warning, risk 
reduction and 
management of 
national and global 
health risks 
Collection, 
management and 
analysis of 
surveillance data 
Epidemiological 
surveillance; 
intersectoral 
coordination; 
diagnostic 
capacity 
Detect 2,3: Real-
time surveillance 
SDG 3.d Early 
warning, risk 
reduction and 
management of 
national and global 
health risks 
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One Sentence Summary:  
Global surveillance capacity for emerging infections can be improved by focusing on 
currently relevant diseases in low- and middle-income settings. 
 
  
  2 
Abstract:  
Emerging infectious diseases (EIDs) threaten the health of people, animals and crops 
globally but our ability to predict their occurrence is limited. Current public health 
capacity and ability to detect and respond to EIDs is typically weakest in low- and 
middle-income countries (LMICs). Many known drivers of EID emergence also converge 
in LMICs. Strengthening capacity for surveillance of diseases of relevance to local 
populations can provide a mechanism for building the cross-cutting and flexible 
capacities needed to tackle both the burden of existing diseases and EID threats. A focus 
on locally-relevant diseases in LMICs and the economic, social and cultural contexts of 
surveillance can help address existing inequalities in health systems, improve the capacity 
to detect and contain EIDs and contribute to broader global goals for development. 
 
Main Text:  
For an increasingly inter-connected planet, emerging infectious diseases (EIDs) pose 
profound threats to human health, the animals and crops we depend upon, and ultimately 
the economies and societies that sustain us. While there is widespread recognition of the 
need for effective surveillance, there is less clarity about how to achieve this. Approaches 
that promise the ability to predict and thus prevent disease outbreaks have obvious 
attraction (1). However, despite important insights into the dynamics of cross-species 
transmission (2, 3), risk factors associated with EID events (4-6), and determinants of 
spread and persistence (3, 7), we still have limited ability to identify when and where new 
disease events will occur. 
 
  3 
The current state of global capacity for EID surveillance shows geographic variation in 
outbreak distribution, detection and reporting times. Over half (53%) of all outbreaks 
reported to WHO (1996-2009) were from Africa, the region with the longest delays in 
detection and public communication (8). Globally, delays are inversely related to the 
Human Development Index (9). Despite the implementation of the International Health 
Regulations (IHR) (10), which mandate countries to develop surveillance systems and 
response capacities to contain epidemics, fewer than 20% of UN member states have 
achieved the required standards (11). 
 
The absence and/or breakdown of public health measures has been identified as by far the 
most important factor underlying the occurrence of infectious disease outbreaks of 
international concern (12). Although the precise location of the next EID event cannot be 
predicted, regions where public health capacity is currently weak are readily identifiable: 
typically in low- and middle-income countries (LMICs) where many of the known 
drivers of EID emergence (deforestation, rapid urbanization and agricultural 
intensification (13)) also converge. For wildlife-associated EIDs, emergence events occur 
most often where dense human populations intersect with areas of high species richness 
(5), again, mostly in LMICs. There is thus a clear rationale for strengthening disease 
surveillance in LMICs. 
 
Surveillance systems and responsive interventions are often designed for a specific 
disease, however, many components of surveillance and response systems are not 
disease-specific. Numerous surveillance systems and organizations, established originally 
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with a focus on a specific locally relevant disease have subsequently leveraged their 
capacities to tackle other threats, including EIDs. For example, laboratories established 
through the Global Polio Eradication Initiative have expanded to cover pathogens 
including hemorrhagic fevers, Japanese encephalitis, SARS, H5N1 and, most recently, 
Ebola virus disease (14, 15). The International Centre for Diarrhoeal Disease Research, 
Bangladesh (icddr,b) established as a cholera research laboratory now conducts research 
into diverse public health threats across a wider region. The predecessor organization of 
the US Centers for Disease Control and Prevention was established to control malaria, 
and cholera control was the initial impetus for the creation of today’s Pan American 
Health Organisation (PAHO) and World Health Organization (WHO).  In the veterinary 
sector, the infrastructures established through the Pan African Rinderpest Campaign are 
now central to the FAO Emergency Prevention System for Transboundary Animal and 
Plant Pests and Disease (EMPRES). The participatory epidemiology approaches and 
improved animal health delivery systems for marginalized communities developed for 
Rinderpest have since been applied to control peste des petit ruminants (PPR), Rift 
Valley fever, highly pathogenic avian influenza (HPAI) and foot-and-mouth disease (16).  
Specific advantages of eradication programs, in terms of legacy effects, emerge from 
their broad geographic scope and networks of trained health workers. The need to 
demonstrate freedom from disease requires verifiable and rigorous targets be met even in 
the most hard to reach communities (16). 
 
EID surveillance requires a network of trained reporters who can recognize and 
communicate disease events and systems to receive, collate and disseminate reports. As 
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the majority of EIDs are zoonoses, integration of surveillance capacities across human 
and animal health sectors is needed (1, 5, 11). Crucially, disease surveillance and the 
implementation and evaluation of interventions to contain the disease threat must be 
linked. Surveillance data inform control measures and useful responses incentivize future 
data collection and reporting (Fig 1) (1). Investments in sustainable surveillance 
programs must ultimately be linked to tangible health improvement outcomes (17). 
 
Prioritizing action to tackle existing diseases 
A focus on strengthening capacity for surveillance of existing diseases that are of 
relevance to local populations can provide a mechanism for building the adaptable 
surveillance capacities that are also needed to tackle EID threats. Our rationale is that the 
act of focusing on locally-relevant and ongoing disease threats enables greater local 
engagement and improves the chances of successful disease control by recognizing the 
social determinants of health (17-19). “Soft” organizational capacities including 
communication, trust building, diplomacy, networking, political advocacy and leadership 
are critical for health systems improvement (19). Aligning capacity strengthening for 
EIDs with locally-relevant disease control efforts can overcome many of the challenges 
inherent in building de novo systems for EIDs. Additional benefits to such a pragmatic 
approach include synergies with multiple Sustainable Development Goals (SDGs) (12, 
17). 
 
There are several existing frameworks that can be used to evaluate surveillance capacities 
and identify capacity-strengthening needs for both EIDs and existing disease challenges. 
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These include the Performance of Veterinary Services (PVS) pathway of the World 
Organisation for Animal Health (OIE), International Health Regulation (IHR) targets 
(10), tools defining core competencies for surveillance at the human-animal interface (20) 
and tools for zoonotic disease prioritization developed through the Global Health 
Security Agenda (GHSA) (21). One health approaches are important for zoonotic disease 
risks but equally, tackling non-zoonotic human diseases or, economically-important 
livestock diseases may be the most effective way to build the capacity needed in many 
cases. No single approach to the selection of locally-relevant diseases (be they infectious, 
non-communicable, endemic or emerging) will be appropriate in all settings. A case 
study illustrating how actions to control rabies, a locally relevant zoonosis in many 
LMICs, contribute to strengthening of surveillance capacities for EIDs and global goals 
for sustainable development is given in Table S1. 
 
Understanding surveillance in context 
Surveillance is costly, hence any perceived lack of benefits is particularly discouraging 
for stakeholders including patients, livestock keepers, healthcare providers and 
governments. Aligning private incentives with local and global public benefits is key and 
a focus on locally-relevant disease problems can help achieve this. Surveillance costs to 
livestock keepers, for example, may include time contacting a private- or public-sector 
animal health official and paying for their services, actions that require a clear private 
benefit to that farmer. In the absence of effective veterinary responses, surveillance 
relying on individual livestock keepers will collapse. This is all to often the case for 
animal (and human) health surveillance initiatives in many LMIC settings, with the 
  7 
unsurprising result that endemic diseases are chronically underreported. Where 
surveillance is focused on potential disease threats, and the nature of the appropriate 
response to a novel threat is unknown, the potential benefits of participation are 
impossible to measure, thus compounding this problem. 
 
The potential benefits of disease reporting actions by a livestock keeper range from 
private benefits, when early detection and reporting minimize income loss from sick 
animals to the spill-over benefits to other local households from reduced disease 
incidence.  Further, there will be national benefits, such as human health risk reductions 
of zoonoses, economic benefits of a healthier livestock sector, and reduced transmission 
from and to wildlife (22).  Finally, there will be advantages from the increased capacity 
to detect EIDs rapidly and minimize their spread and impact world-wide. The wider 
ranging benefits are less tangible to individual livestock keepers and of little incentive. 
Despite these far reaching benefits, the major surveillance costs fall on local stakeholders, 
who will only partially gain benefits. For national or global programs to be able to rely on 
grassroots disease monitoring, it is important to ensure that individuals benefit by 
subsidizing or rewarding participation in surveillance activities, for example via incentive 
payments or through involvement with institutions created for coordination and benefit 
sharing across communities.  These could include, for example, cooperatives of livestock 
farmers acting together on surveillance and disease control behavior to generate greater 
benefits in total than if each person acted according to individual interests and provides a 
mechanism for sharing these benefits.  It is important to identify who should fund such 
programs and how best to design cooperative institutions (23). 
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If the long-term outcome is improved global capacity to detect and respond to EIDs, the 
entire global population benefits. A key question therefore is whether richer beneficiaries 
should pay for surveillance by the individuals who supply this public good. If so, 
investments in tackling diseases in LMICs that will improve global EID surveillance 
capacity should be funded by Western governments, development banks or aid agencies. 
The design of systems to tackle misalignments of costs and benefits must also consider 
the best form in which incentives can be provided (1). Theoretical models that identify 
when it is best to subsidize actions rather than outcomes, or a combination of the two, 
provide compelling solutions to analogous questions in biodiversity conservation (24). 
 
New technologies, including mobile phones have potential to facilitate real-time 
communication and improve surveillance capacity if adopted for routine use. For 
example, a recent large-scale mobile-phone based system in southern Tanzania improved 
rabies surveillance data quality and timeliness at low cost in comparison to paper-based 
surveillance (25). Regular phone communications and feedback supported users, 
particularly in isolated areas, and incentivized surveillance. Importantly, this system was 
designed by government representatives, community members and system users. 
Integrating these technologies within widely used surveillance platforms such as DHIS2, 
could facilitate their uptake and simplify demands on health and veterinary workers (26). 
 
Public health interventions often fail because of a lack of attention to their social, cultural 
and historical contexts and engagement with the people they are designed to benefit. 
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Effective community engagement has been crucial for successful control of Ebola in 
West Africa (27), rinderpest eradication (16) and the success of many Neglected Tropical 
Disease (NTD) programs (28). Indeed, the need to tailor delivery strategies to local 
contexts is a common finding from social science studies of NTD programs (18), and 
there is no reason to think this any less necessary for other infectious disease challenges 
including surveillance (17, 19). 
 
Research is vital to understand the relative importance of disease alongside other 
priorities for individual households, perceptions of ability to effect change, and the 
situations required for action to be taken. Even in the midst of epidemics, attitudes 
towards disease risk and management, for instance, may not be focused around one 
pathogen, or even with avoiding disease at all, but on providing food, income, education 
or investment for the future. Local understandings of disease, relationships to government 
officials and the state, and past experiences with development projects play important 
mediating roles in community engagement with disease control and capacity 
strengthening programs (18, 29). The causes of social difference are complex: it is not 
always possible to address these through individual behavior change and instead, wider 
social, economic and political processes must be understood. One Health approaches 
offer an advantage here because they can offer a broader understanding of the 
interdependencies of human, animal, environmental and socio-economic health in the 
decision-making of households, in addition to the likely impacts of disease control 
interventions. However, interventions are unlikely to be adopted if individuals perceive 
that they lack the agency to enact change. Focusing on tangible and tractable current 
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problems can help to empower individuals. 
 
Maximizing synergies and sustainability 
By focusing on detecting and reporting rare EID events independently of other disease 
problems, we miss important opportunities for broader-reaching benefits and synergies. 
Appropriately targeted improvements in surveillance capacity can be viewed as 
investments in a country’s “inclusive wealth”, argued to be a key factor in determining a 
country’s ability to achieve sustained improvements in well-being (30). Our proposed 
strategy reflects a growing global interest in optimizing interactions across the SDGs 
(31). Progress towards the SDG3.d target relating to EIDs - to strengthen capacity of all 
countries, in particular developing countries for early warning, risk reduction and 
management of national and global health risks - depends on several other SDG3 targets, 
including access to good quality essential health-care services. Efforts to manage a 
locally-relevant disease can also contribute to ending neglected tropical diseases 
(SDG3.3) and achieving universal health coverage (SDG3.8). Interventions that support 
targets for sustainable cities and communities (SDG11) could be designed with a view to 
detecting and mitigating emerging vector-borne disease threats, such as Zika, 
Chikungunya and Yellow Fever viruses which are all transmitted by urban-adapted 
species of Aedes mosquito vectors. Interventions to support sustainable and resilient 
agricultural practices that help maintain diverse ecosystems (SDG2) could be developed 
to mitigate against the land-use changes that have been linked with spill-over 
transmission and disease emergence from wildlife reservoirs.  
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The components and requirements of effective global EID surveillance are known, but 
there has been less focus on the mechanisms that can be employed to strengthen the 
capacities needed. This is particularly true in LMICs with the weakest human and animal 
health systems, where many diseases have emerged and where the consequences of EID 
events are likely to be most serious. Many of the capacities required for EID surveillance 
are identical to those required to tackle existing diseases of ongoing local importance. We 
argue for an approach whereby gaps in EID surveillance capacity are filled by responding 
to existing local health challenges rather than through a focus on EIDs exclusively. The 
investments required to achieve comparable capacity gains through an ‘EID only’ 
strategy are likely to be greater and ultimately unsustainable. In contrast, approaches to 
EID capacity building that address locally-relevant disease problems can capitalize on 
positive reinforcement processes that will sustain the capacities and collaborative 
networks that make up a functional surveillance system. By addressing ongoing disease 
problems, greater understanding of the social determinants and context of disease 
response capability in low-resource settings can be built, generating insights that apply 
far beyond the initial target disease. This approach provides a mechanism for achieving 
the necessary improvements in global EID surveillance capacity while also contributing 
to broader global goals for development. 
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Fig. 1: Surveillance cycles for current and potential disease problems.  
The lower cycle illustrates the self-reinforcing nature of effective surveillance processes 
for existing disease problems. The upper cycle illustrates the equivalent processes for 
potential disease problems. Because it is difficult to implement interventions for potential 
disease threats that provide a useful response and thus motivate further grassroots data 
collection, this cycle is less intrinsically sustainable, limiting the long-term effectiveness 
of approaches that focus on EIDs and potential threats alone. The vertical arrows show 
how capacity for potential disease problems and EID surveillance overall can be built by 
‘borrowing’ critical capacities (shown by the vertical arrows) from approaches that focus 
on existing diseases. Figure drawn by F. Zsolnai. 
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